Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Firzan Nainu, Rufika Shari Abidin, Muh. Akbar Bahar, Andri Frediansyah, Talha Bin Emran, Ali A Rabaan, Kuldeep Dhama & Harapan Harapan. (2020) SARS-CoV-2 reinfection and implications for vaccine development. Human Vaccines & Immunotherapeutics 16:12, pages 3061-3073.
Read now
Read now
Joseph U Igietseme, Francis O Eko & Carolyn M Black. (2011) Chlamydia vaccines: recent developments and the role of adjuvants in future formulations. Expert Review of Vaccines 10:11, pages 1585-1596.
Read now
Read now
Articles from other publishers (16)
Ghada Elfayres, Ricky Raj Paswan, Laura Sika, Marie-Pierre Girard, Soumia Khalfi, Claire Letanneur, Kéziah Milette, Amita Singh, Gary Kobinger & Lionel Berthoux. (2023) Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particles. Journal of Virological Methods 322, pages 114835.
Crossref
Crossref
Tirtha Tarafdar. (2022) A brief go-to on the epidemiology of Malariaand the usage of virus like particles (VLPs) as a novel immunogenic vaccine platform. American Journal of Applied Bio-Technology Research 3:3, pages 4-16.
Crossref
Crossref
Ernesto Garay, Diego Fontana, Lautaro Leschiutta, Ricardo Kratje & Claudio Prieto. (2021) Rational design of novel fusion rabies glycoproteins displaying a major antigenic site of foot-and-mouth disease virus for vaccine applications. Applied Microbiology and Biotechnology 106:2, pages 579-592.
Crossref
Crossref
Yu Wang, Gang Wang, Wei-Tong Duan, Ming-Xia Sun, Meng-Hang Wang, Shang-Hui Wang, Xue-Hui Cai & Ya-bin Tu. (2020) Self-assembly into virus–like particles of the recombinant capsid protein of porcine circovirus type 3 and its application on antibodies detection. AMB Express 10:1.
Crossref
Crossref
Diego Fontana, Federico Marsili, Marina Etcheverrigaray, Ricardo Kratje & Claudio Prieto. (2020) Rabies VLPs adjuvanted with saponin-based liposomes induce enhanced immunogenicity mediated by neutralizing antibodies in cattle, dogs and cats. Journal of Virological Methods 286, pages 113966.
Crossref
Crossref
Chun-Wei Chen, Narcís Saubi & Joan Joseph-Munné. (2020) Design Concepts of Virus-Like Particle-Based HIV-1 Vaccines. Frontiers in Immunology 11.
Crossref
Crossref
Jerri C. Caldeira, Michael Perrine, Federica Pericle & Federica Cavallo. (2020) Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines. Viruses 12:5, pages 488.
Crossref
Crossref
Dan Yan, Yan-Quan Wei, Hui-Chen Guo & Shi-Qi Sun. (2015) The application of virus-like particles as vaccines and biological vehicles. Applied Microbiology and Biotechnology 99:24, pages 10415-10432.
Crossref
Crossref
R. S. Abidin, L. H. L. Lua, A. P. J. Middelberg & F. Sainsbury. (2015) Insert engineering and solubility screening improves recovery of virus-like particle subunits displaying hydrophobic epitopes. Protein Science 24:11, pages 1820-1828.
Crossref
Crossref
Diego Fontana, Ricardo Kratje, Marina Etcheverrigaray & Claudio Prieto. (2015) Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate. Vaccine 33:35, pages 4238-4246.
Crossref
Crossref
Yi Chen, Yan Zhang, Can Quan, Jian Luo, Yanli Yang, Mengran Yu, Yingjun Kong, Guanghui Ma & Zhiguo Su. (2015) Aggregation and antigenicity of virus like particle in salt solution—A case study with hepatitis B surface antigen. Vaccine 33:35, pages 4300-4306.
Crossref
Crossref
Hongtao Kang, Yinglin Qi, Hualei Wang, Xuexing Zheng, Yuwei Gao, Nan Li, Songtao Yang & Xianzhu Xia. (2015) Chimeric Rabies Virus-Like Particles Containing Membrane-Anchored GM-CSF Enhances the Immune Response against Rabies Virus. Viruses 7:3, pages 1134-1152.
Crossref
Crossref
Yinglin Qi, Hongtao Kang, Xuexing Zheng, Hualei Wang, Yuwei Gao, Songtao Yang & Xianzhu Xia. (2015) Incorporation of membrane-anchored flagellin or Escherichia coli heat-labile enterotoxin B subunit enhances the immunogenicity of rabies virus-like particles in mice and dogs. Frontiers in Microbiology 6.
Crossref
Crossref
Diego Fontana, Ricardo Kratje, Marina Etcheverrigaray & Claudio Prieto. (2014) Rabies virus-like particles expressed in HEK293 cells. Vaccine 32:24, pages 2799-2804.
Crossref
Crossref
Khairunadwa Jemon, Vivienne Young, Michelle Wilson, Sara McKee, Vernon Ward, Margaret Baird, Sarah Young & Merilyn Hibma. (2013) An Enhanced Heterologous Virus-Like Particle for Human Papillomavirus Type 16 Tumour Immunotherapy. PLoS ONE 8:6, pages e66866.
Crossref
Crossref
R. Koukuntla, R. B. Mandell & R. Flick. (2012) Virus-Like Particle-Based Countermeasures Against Rift Valley Fever Virus. Zoonoses and Public Health 59, pages 142-150.
Crossref
Crossref